The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
Open accessAbstract
Purpose: An estimated 10% of breast and ovarian cancers result from hereditary causes. Current testing guidelines for germ line susceptibility genes in patients with breast carcinoma were developed to identify carriers of BRCA1/ 2 variants and have evolved in the panel-testing era. We evaluated the capability of the National Comprehensive Cancer Network (NCCN) guidelines to identify patients with breast cancer with pathogenic variants in expanded panel testing. Methods: An institutional review board–approved multicenter prospective registry was initiated with 20 community and academic sites experienced in cancer genetic testing and counseling. Eligibility criteria included patients with a previously or newly diagnosed breast cancer who had not undergone either single- or multigene testing. Consecutive patients 18 to 90 years of age were consented and underwent an 80-gene panel test. Health Insurance Portability and Accountability Act–compliant electronic case report forms collected information on patient demographics, diagnoses, phenotypes, and test results. Results: More than 1,000 patients were enrolled, and data records for 959 patients were analyzed; 49.95% met NCCN criteria, and 50.05% did not. Overall, 8.65% of patients had a pathogenic/likely pathogenic (P/LP) variant. Of patients who met NCCN guidelines with test results, 9.39% had a P/LP variant. Of patients who did not meet guidelines, 7.9% had a P/LP variant. The difference in positive results between these groups was not statistically significant (Fisher’s exact test P = .4241). Conclusion: Our results indicate that nearly half of patients with breast cancer with a P/LP variant with clinically actionable and/or management guidelines in development are missed by current testing guidelines. We recommend that all patients with a diagnosis of breast cancer undergo expanded panel testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Robson, M., Im, S.-A., Senkus, E., Xu, B., Domchek, S. M., Masuda, N., Delaloge, S., Li, W., Tung, N., Armstrong, A., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1706450 · Cited by 3,294
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
Pritchard, C. C., Mateo, J., Walsh, M. F., De Sarkar, N., Abida, W., Beltran, H., Garofalo, A., Gulati, R., Carreira, S., Eeles, R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603144 · Cited by 1,680
Saam, J., Arnell, C., Theisen, A., Moyes, K., Marino, I., Roundy, K. M., & Wenstrup, R. J. (2015) · Oncology · doi:10.1159/000437307 · Cited by 1,526
Inherited Mutations in Women With Ovarian Carcinoma
Norquist, B. M., Harrell, M. I., Brady, M. F., Walsh, T., Lee, M. K., Gulsuner, S., Bernards, S. S., Casadei, S., Yi, Q., Burger, R. A., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.5495 · Cited by 769
Sherloc: a comprehensive refinement of the ACMG–AMP variant classification criteria
Nykamp, K., Anderson, M., Powers, M., Garcia, J., Herrera, B., Ho, Y.-Y., Kobayashi, Y., Patil, N., Thusberg, J., Westbrook, M., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.37 · Cited by 762
Tung, N., Lin, N. U., Kidd, J., Allen, B. A., Singh, N., Wenstrup, R. J., Hartman, A.-R., Winer, E. P., & Garber, J. E. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.0747 · Cited by 556
Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment
Kurian, A. W., Hare, E. E., Mills, M. A., Kingham, K. E., McPherson, L., Whittemore, A. S., McGuire, V., Ladabaum, U., Kobayashi, Y., Lincoln, S. E., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.6607 · Cited by 485
Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma
Shindo, K., Yu, J., Suenaga, M., Fesharakizadeh, S., Cho, C., Macgregor-Das, A., Siddiqui, A., Witmer, P. D., Tamura, K., Song, T. J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.3502 · Cited by 458
Buys, S. S., Sandbach, J. F., Gammon, A., Patel, G., Kidd, J., Brown, K. L., Sharma, L., Saam, J., Lancaster, J., & Daly, M. B. (2017) · Cancer · doi:10.1002/cncr.30498 · Cited by 399
National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer
Childers, C. P., Childers, K. K., Maggard-Gibbons, M., & Macinko, J. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.6314 · Cited by 351
Susswein, L. R., Marshall, M. L., Nusbaum, R., Vogel Postula, K. J., Weissman, S. M., Yackowski, L., Vaccari, E. M., Bissonnette, J., Booker, J. K., Cremona, M. L., et al. (2016) · Genetics in Medicine · doi:10.1038/gim.2015.166 · Cited by 287
Provenzale, D., Gupta, S., Ahnen, D. J., Bray, T., Cannon, J. A., Cooper, G., David, D. S., Early, D. S., Erwin, D., Ford, J. M., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0108 · Cited by 255
Manickam, K., Buchanan, A. H., Schwartz, M. L. B., Hallquist, M. L. G., Williams, J. L., Rahm, A. K., Rocha, H., Savatt, J. M., Evans, A. E., Butry, L. M., et al. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.2140 · Cited by 208
Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer
Evans, D. G. R., Ingham, S. L., Baildam, A., Ross, G. L., Lalloo, F., Buchan, I., & Howell, A. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2583-1 · Cited by 178
Hampel, H., Pearlman, R., Beightol, M., Zhao, W., Jones, D., Frankel, W. L., Goodfellow, P. J., Yilmaz, A., Miller, K., Bacher, J., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.0104 · Cited by 172
Drohan, B., Roche, C. A., Cusack, J. C., & Hughes, K. S. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2257-y · Cited by 128
Self-citationYadav, S., Hu, C., Hart, S. N., Boddicker, N. J., Polley, E. C., Na, J., Gnanaolivu, R. D., Lee, K. Y., Lindstrom, T., Armasu, S. M., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02190 · Cited by 121
Tuffaha, H., Mitchell, A., Ward, R. L., Connelly, L. B., Butler, J. R. G., Norris, S., & Scuffham, P. (2018) · Genetics in Medicine · doi:10.1038/gim.2017.231 · Cited by 114
Cohen, S. A., Marvin, M. L., Riley, B. D., Vig, H. S., Rousseau, J. A., & Gustafson, S. L. (2013) · Journal of Genetic Counseling · doi:10.1007/s10897-013-9588-0 · Cited by 108
Yang, S., Axilbund, J. E., O’Leary, E., Michalski, S. T., Evans, R., Lincoln, S. E., Esplin, E. D., & Nussbaum, R. L. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6621-4 · Cited by 85
Self-citationCohen, S. A., Gustafson, S. L., Marvin, M. L., Riley, B. D., Uhlmann, W. R., Liebers, S. B., & Rousseau, J. A. (2012) · Journal of Genetic Counseling · doi:10.1007/s10897-012-9505-y · Cited by 82
Use of BRCA Mutation Test in the U.S., 2004–2014
Guo, F., Hirth, J. M., Lin, Y., Richardson, G., Levine, L., Berenson, A. B., & Kuo, Y. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.01.027 · Cited by 74
O’Leary, E., Iacoboni, D., Holle, J. R., Michalski, S. T., Esplin, E. D., Yang, S., & Ouyang, K. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-5963-7 · Cited by 66
Self-citationLatin American Study of Hereditary Breast and Ovarian Cancer LACAM: A Genomic Epidemiology Approach
Oliver, J., Urban, R. Q., Cortés, C. A. F., Velásquez, C. E. D., Montealegre, A. L., Pacheco-Orozco, R. A., Castro-Rojas, C. A., García‐Robles, R., Rivera, J. J. L., Chaparro, S. G., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01429 · Cited by 57
Cohen, S. A., & Nixon, D. M. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3964-z · Cited by 41
Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women
Patel, S., Legood, R., Evans, D. G., Turnbull, C., Antoniou, A. C., Menon, U., Jacobs, I. J., & Manchanda, R. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.12.221 · Cited by 38
van Marcke, C., Helaers, R., Leener, A. D., Merhi, A., Schoonjans, C. A., Ambroise, J., Galant, C., Delrée, P., Rothé, F., Bar, I., et al. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01273-y · Cited by 26
Bernhardt, B. A., Geller, G., Doksum, T., & Metz, S. A. (2000) · PubMed · Cited by 24
Cited by
Tung, N. M., Robson, M. E., Ventz, S., Santa-Maria, C. A., Nanda, R., Marcom, P. K., Shah, P. D., Ballinger, T. J., Yang, E. S., Vinayak, S., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.02151 · Cited by 508
Kurian, A. W., Ward, K. C., Howlader, N., Deapen, D., Hamilton, A. S., Mariotto, A., Miller, D., Penberthy, L. S., & Katz, S. J. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01854 · Cited by 387
Manahan, E. R., Kuerer, H. M., Sebastian, M., Hughes, K. S., Boughey, J. C., Euhus, D. M., Boolbol, S. K., & Taylor, W. A. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07549-8 · Cited by 346
Self-citationSamadder, N. J., Riegert-Johnson, D., Boardman, L., Rhodes, D., Wick, M., Okuno, S., Kunze, K. L., Golafshar, M., Uson, P. L. S., Mountjoy, L., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2020.6252 · Cited by 304
Self-citationESO–ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)
Paluch-Shimon, S., Cardoso, F., Partridge, A. H., Abulkhair, O., Azim, H. A., Bianchi-Micheli, G., Cardoso, M.-J., Curigliano, G., Gelmon, K. A., Harbeck, N., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.03.284 · Cited by 254
Metadata
- Authors
- Beitsch, P. D., Whitworth, P. W., Hughes, K., Patel, R., Rosen, B., Compagnoni, G., Baron, P., Simmons, R., Smith, L. A., Grady, I., Kinney, M., Coomer, C., Barbosa, K., Holmes, D. R., Brown, E., Gold, L., Clark, P., Riley, L., Lyons, S., Ruiz, A., Kahn, S., MacDonald, H., Curcio, L., Hardwick, M. K., Yang, S., Esplin, E. D., & Nussbaum, R. L.
- Venue
- Journal of Clinical Oncology
- Published
- 2019-02-20
- Volume
- 37
- Issue
- 6
- Pages
- 453-460
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2905048441
- Cited by
- 363
- References
- 28
- FWCI
- 20.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.